Design Therapeutics, Inc.Design Therapeutics, Inc.Design Therapeutics, Inc.

Design Therapeutics, Inc.

No trades
See on Supercharts

Price target

7.000.000.00%
The 3 analysts offering 1 year price forecasts for DSGN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to DSGN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


DSGN EPS for the last quarter is −0.23 USD despite the estimation of −0.24 USD. In the next quarter EPS is expected to reach −0.27 USD. Track more of Design Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Design Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Design Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, DSGN price target is 7.00 USD with a max estimate of 12.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Design Therapeutics, Inc. stock price chart and keep track of the current situation with DSGN news and stock market news.